SURVANTA (beractant) Survanta For the treatment and prevention
Health Care Professionals Parent Information Prescribing Information
 
Home
Download the 2007 NeoFax Manual.
Click Here

Watch the Survanta Dosing Video
Click Here

Download the National Respiratory Disease Newsletter
Click Here

Health Care ProfessionalsOver 800,000 infants treated since 1991*
Clinical Studies
Additional Studies
Follow-Up Studies
Prenatal Corticosteroids and Postnatal Surfactant
Epidemiologic Research
Surfactant Therapy Overview

Epidemiologic Research

Schwartz RM, Luby AM, Scanlon JW, Kellogg RJ: Effect of surfactant on morbidity, mortality, and resource use in newborn infants weighing 500 to 1500 g.
N Engl J Med 1994;330:1476-1480.

Horbar JD, Wright EC, Onstad L: Decreasing mortality associated with the introduction of surfactant therapy: An observational study of neonates weighing 601 to 1300 grams at birth.
Pediatrics 1993;92:191-196.

Hoekstra RE, Ferrara TB, Payne NR: Effects of surfactant therapy on outcome of extremely premature infants.
Eur J Pediatr 1994;153:S12-S16.

* IMS DDD Lung Surfactant Market Purchases July 1991 through June 2008. On file, Abbott Nutrition Marketing Research.